Search Results - "RICH, Tyvin A"

Long-Term Update of US GI Intergroup RTOG 98-11 Phase III Trial for Anal Carcinoma: Survival, Relapse, and Colostomy Failure With Concurrent Chemoradiation Involving Fluorouracil/Mitomycin Versus Fluorouracil/Cisplatin by GUNDERSON, Leonard L, WINTER, Kathryn A, WILLETT, Christopher G, AJANI, Jaffer A, PEDERSEN, John E, MOUGHAN, Jennifer, BENSON, Al B, THOMAS, Charles R, MAYER, Robert J, HADDOCK, Michael G, RICH, Tyvin A

“…On initial publication of GI Intergroup Radiation Therapy Oncology Group (RTOG) 98-11 [A Phase III Randomized Study of 5-Fluorouracil (5-FU), Mitomycin, and…”
Get full text

Failure to Adhere to Protocol Specified Radiation Therapy Guidelines Was Associated With Decreased Survival in RTOG 9704—A Phase III Trial of Adjuvant Chemotherapy and Chemoradiotherapy for Patients With Resected Adenocarcinoma of the Pancreas by Abrams, Ross A., M.D, Winter, Kathryn A., M.S, Regine, William F., M.D, Safran, Howard, M.D, Hoffman, John P., M.D, Lustig, Robert, M.D, Konski, Andre A., M.D, Benson, Al B., M.D, Macdonald, John S., M.D, Rich, Tyvin A., M.D, Willett, Christopher G., M.D

“…Purpose In Radiation Therapy Oncology Group 9704, as previously published, patients with resected pancreatic adenocarcinoma received continuous infusion 5-FU…”
Get full text

Preoperative Capecitabine and Concurrent Radiation for Borderline Resectable Pancreatic Cancer by Stokes, Jayme B., Nolan, Norris J., Stelow, Edward B., Walters, Dustin M., Weiss, Geoffrey R., de Lange, Eduard E., Rich, Tyvin A., Adams, Reid B., Bauer, Todd W.

“…Background Patients with borderline resectable pancreatic ductal adenocarcinoma (PDA) represent a high-risk group of patients due to tumor or patient-related…”
Get full text

Anal Carcinoma: Impact of TN Category of Disease on Survival, Disease Relapse, and Colostomy Failure in US Gastrointestinal Intergroup RTOG 98-11 Phase 3 Trial by Gunderson, Leonard L., MD, Moughan, Jennifer, Ajani, Jaffer A., MD, Pedersen, John E., MD, Winter, Kathryn A, Benson, Al B., MD, Thomas, Charles R., MD, Mayer, Robert J., MD, Haddock, Michael G., MD, Rich, Tyvin A., MD, Willett, Christopher G., MD

“…Purpose The long-term update of US GI Intergroup RTOG 98-11 anal cancer trial found that concurrent chemoradiation (CCRT) with fluorouracil (5-FU) plus…”
Get full text

Phase II Trial of Preoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma (RTOG 9904): Quality of Combined Modality Therapy and Pathologic Response by AJANI, Jaffer A, WINTER, Kathryn, RICH, Tyvin A, OKAWARA, Gordon S, DONOHUE, John H, PISTERS, Peter W. T, CRANE, Christopher H, GRESKOVICH, John F, RANI ANNE, P, BRADLEY, Jeffrey D, WILLETT, Christopher

“…Preoperative therapy for localized gastric cancer has considerable appeal. We hypothesized that, in a cooperative group setting, preoperative chemoradiotherapy…”
Get full text

Phase II Study of Bevacizumab With Concurrent Capecitabine and Radiation Followed by Maintenance Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer: Radiation Therapy Oncology Group RTOG 0411 by CRANE, Christopher H, WINTER, Kathryn, REGINE, William F, SAFRAN, Howard, RICH, Tyvin A, CURRAN, Walter, WOLFF, Robert A, WILLETT, Christopher G

“…The primary objective of this study was to assess the 1-year survival of patients with locally advanced, unresectable pancreatic cancer treated with the…”
Get full text

Four Decades of Continuing Innovation With Fluorouracil: Current and Future Approaches to Fluorouracil Chemoradiation Therapy by RICH, Tyvin A, SHEPARD, Robert C, MOSLEY, Stephen T

“…Chemoradiotherapy, the combination of external radiation therapy and concurrent chemotherapy, has been the basis for the oncologic management of many patients…”
Get full text

Impact of T and N Stage and Treatment on Survival and Relapse in Adjuvant Rectal Cancer A Pooled Analysis by GUNDERSON, Leonard L, SARGENT, Daniel J, MARTENSON, James A, MAYER, Robert J, RICH, Tyvin A, AJANI, Jaffer A, MACDONALD, John S, WILLETT, Christopher G, GOLDBERG, Richard M, TEPPER, Joel E, WOLMARK, Norman, O'CONNELL, Michael J, BEGOVIC, Mirsada, ALLMER, Cristine, COLANGELO, Linda, SMALLEY, Steven R, HALLER, Daniel G

“…To determine survival and relapse rates by T and N stage and treatment method in five randomized phase III North American rectal adjuvant studies. Data were…”
Get full text

Accelerated treatment using intensity‐modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma by McIntosh, Alyson, Hagspiel, Klaus D., Al‐Osaimi, Abdullah M., Northup, Patrick, Caldwell, Stephen, Berg, Carl, Angle, J. Fritz, Argo, Curtis, Weiss, Geoffrey, Rich, Tyvin A.

“…BACKGROUND: Patients with unresectable hepatocellular carcinoma (HCC) have limited treatment options. In this study, the authors investigated the feasibility,…”
Get full text

US Intergroup Anal Carcinoma Trial: Tumor Diameter Predicts for Colostomy by AJANI, Jaffer A, WINTER, Kathryn A, GUNDERSON, Leonard L, PEDERSEN, John, BENSON, Al B, THOMAS, Charles R, MAYER, Robert J, HADDOCK, Michael G, RICH, Tyvin A, WILLETT, Christopher G

“…The US Gastrointestinal Intergroup Radiation Therapy Oncology Group 98-11 anal carcinoma trial showed that cisplatin-based concurrent chemoradiotherapy…”
Get full text

Phase III Trial of Fluorouracil-Based Chemotherapy Regimens Plus Radiotherapy in Postoperative Adjuvant Rectal Cancer: GI INT 0144 by SMALLEY, Stephen R, BENEDETTI, Jacqueline K, BENSON, Al B, HALLER, Daniel G, MAYER, Robert J, ATKINS, James N, CRIPPS, Christine, PEDERSEN, John, PERIMAN, Phillip O, TANAKA, Michael S, LEICHMAN, Cynthia G, MACDONALD, John S, WILLIAMSON, Stephen K, ROBERTSON, John M, ESTES, Norman C, MAHER, Tracy, FISHER, Barbara, RICH, Tyvin A, MARTENSON, Fames A, KUGLER, John W

“…Adjuvant chemoradiotherapy after or before resection of high-risk rectal cancer improves overall survival (OS) and pelvic control. We studied three…”
Get full text

Preoperative Chemoradiation for Rectal Cancer Using Capecitabine and Celecoxib Correlated With Posttreatment Assessment of Thymidylate Synthase and Thymidine Phosphorylase Expression by Unger, Keith R., M.D, Romney, Davis A., M.D, Koc, Mehmet, M.D, Moskaluk, Christopher. A., M.D, Friel, Charles M., M.D, Foley, E.F., M.D, Rich, Tyvin A., M.D

“…Purpose Thymidylate synthase (TS) and thymidine phosphorylase (TP) expression have been shown to be predictors of response to therapy. The toxicity, efficacy,…”
Get full text

Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal: A Randomized Controlled Trial by Ajani, Jaffer A, Winter, Kathryn A, Gunderson, Leonard L, Pedersen, John, Benson, Al B, Thomas, Charles R, Mayer, Robert J, Haddock, Michael G, Rich, Tyvin A, Willett, Christopher

“…CONTEXT Chemoradiation as definitive therapy is the preferred primary therapy for patients with anal canal carcinoma; however, the 5-year disease-free survival…”
Get full text

Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the U.S. Intergroup/RTOG 9704 Phase III Trial by Regine, William F., Winter, Kathryn A., Abrams, Ross, Safran, Howard, Hoffman, John P., Konski, Andre, Benson, Al B., Macdonald, John S., Rich, Tyvin A., Willett, Christopher G.

“…Background The impact of the addition of gemcitabine to 5-fluorouracil (5-FU) chemoradiation (CRT) on 5-year overall survival (OS) in resected pancreatic…”
Get full text

Fluorouracil vs Gemcitabine Chemotherapy Before and After Fluorouracil-Based Chemoradiation Following Resection of Pancreatic Adenocarcinoma: A Randomized Controlled Trial by Regine, William F, Winter, Kathryn A, Abrams, Ross A, Safran, Howard, Hoffman, John P, Konski, Andre, Benson, Al B, Macdonald, John S, Kudrimoti, Mahesh R, Fromm, Mitchel L, Haddock, Michael G, Schaefer, Paul, Willett, Christopher G, Rich, Tyvin A

“…CONTEXT Among patients with locally advanced metastatic pancreatic adenocarcinoma, gemcitabine has been shown to improve outcomes compared with fluorouracil…”
Get full text

Prognostic Factors Derived from A Prospective Database Dictate Clinical Biology of Anal Cancer: The Intergroup Trial (RTOG 98-11) by AJANI, Jaffer A, WINTER, Kathryn A, GUNDERSON, Leonard L, PEDERSEN, John, BENSON, Al B, THOMAS, Charles R, MAYER, Robert J, HADDOCK, Michael G, RICH, Tyvin A, WILLETT, Christopher G

“…Only 4 prospective randomized phase 3 trials have been reported for anal cancer. A prognostic factor analysis for anal cancer from a prospective database has…”
Get full text

Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer by Janjan, Nora A, Abbruzzese, James, Pazdur, Richard, Khoo, Vincent S, Cleary, Karen, Dubrow, Ronelle, Ajani, Jaffer, Rich, Tyvin A, Goswitz, Mary S, Evetts, Phyllis A, Allen, Pamela K, Lynch, Patrick M, Skibber, John M

“…Background and purpose: To evaluate the influence of response to preoperative infusional chemoradiation on outcome parameters among patients with locally…”
Get full text

Unresectable Cholangiocarcinoma: Comparison of Survival in Biliary Stenting Alone Versus Stenting With Photodynamic Therapy by Kahaleh, Michel, Mishra, Rajnish, Shami, Vanessa M, Northup, Patrick G, Berg, Carl L, Bashlor, Penny, Jones, Petra, Ellen, Kristi, Weiss, Geoffrey R, Brenin, Christiana M, Kurth, Barbara E, Rich, Tyvin A, Adams, Reid B, Yeaton, Paul

“…Background & Aims: Photodynamic therapy (PDT) for unresectable cholangiocarcinoma is associated with improvement in cholestasis, quality of life, and…”
Get full text

Assessment of Cardiovascular Parameters during Meditation with Mental Targeting in Varsity Swimmers by Gerdt, David, Alton, John, Pfister, Robert, Rich, Tyvin A., Baruch, Martin

“…Introduction. Athletes who develop an immunosuppressed state because of intensive training get upper respiratory infections (URIs) and may respond to…”
Get full text

Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis by Rich, Tyvin A

“…Recent studies in chronobiology and the neurosciences have led to rapid growth in our understanding of the molecular biology of the human timekeeping apparatus…”
Get more information